These sections govern the substitution of lower-priced generically equivalent drug products for certain brand name drug products and the substitution of interchangeable biological products for certain biological products.

Source Note: The provisions of this §309.1 adopted to be effective June 1, 2002, 27 TexReg 1782; amended to be effective December 6, 2015, 40 TexReg 8790